bluebird bio, Inc. — Form D

bluebird bio, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2012-07-25. The offering totals $60.0M, of which $60.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
Daniel S. LynchDirectorCambridge, MA
John M. MaraganoreDirectorCambridge, MA
Jeffrey T. WalshExecutive OfficerCambridge, MA
Nick LeschlyDirectorCambridge, MA
Nick LeschlyExecutive OfficerCambridge, MA
Steven GillisDirectorSouth San Francisco, CA
Chip BairdExecutive OfficerNew York, NY
James A GeraghtyDirectorLexington, MA
Robert TepperDirectorCambridge, MA
Denice R TorresDirectorCAMBRIDGE, MA
William R SellersDirectorCAMBRIDGE, MA
Daniel S LynchDirectorCambridge, MA
Jason ColeExecutive OfficerCambridge, MA
Mark R VachonDirectorCambridge, MA
John S AgwunobiDirectorCambridge, MA
Nick S LeschlyDirectorCambridge, MA
Nick S LeschlyExecutive OfficerCambridge, MA
Wendy S DixonDirectorCambridge, MA
Geert-Jan HC MulderDirectorWaltham, MA
Ramy S IbrahimDirectorCoral Gables, FL
Axel PolackDirectorCambridge, MA
Geert-Jan A MulderDirectorCambridge, MA

Other filings by this issuer (4)

FiledFormOfferingSold
2021-09-21D$75.0M$75.0M
2011-04-27D$30.0M$15.0M
2011-04-27D/A$37.5M$37.5M
2010-03-19D$47.4M$29.4M

More